Principal Financial Group Inc. Takes $1.47 Million Position in Surgery Partners, Inc. (NASDAQ:SGRY)

Principal Financial Group Inc. purchased a new position in Surgery Partners, Inc. (NASDAQ:SGRY) in the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund purchased 45,552 shares of the company’s stock, valued at approximately $1,469,000.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Vanguard Group Inc. grew its holdings in Surgery Partners by 0.8% during the 1st quarter. Vanguard Group Inc. now owns 7,479,009 shares of the company’s stock worth $223,099,000 after acquiring an additional 61,400 shares in the last quarter. Bamco Inc. NY increased its holdings in Surgery Partners by 100.0% in the first quarter. Bamco Inc. NY now owns 90,000 shares of the company’s stock valued at $2,685,000 after buying an additional 45,000 shares during the last quarter. Janus Henderson Group PLC raised its stake in Surgery Partners by 7,987.1% during the first quarter. Janus Henderson Group PLC now owns 2,504,248 shares of the company’s stock valued at $74,701,000 after buying an additional 2,473,282 shares in the last quarter. DekaBank Deutsche Girozentrale raised its stake in Surgery Partners by 102.0% during the first quarter. DekaBank Deutsche Girozentrale now owns 2,723 shares of the company’s stock valued at $80,000 after buying an additional 1,375 shares in the last quarter. Finally, Wesbanco Bank Inc. lifted its holdings in Surgery Partners by 53.4% during the 2nd quarter. Wesbanco Bank Inc. now owns 39,363 shares of the company’s stock worth $936,000 after buying an additional 13,700 shares during the last quarter.

Wall Street Analysts Forecast Growth

SGRY has been the topic of several research reports. Cantor Fitzgerald reissued an “overweight” rating and set a $43.00 price target on shares of Surgery Partners in a research report on Friday, October 4th. UBS Group initiated coverage on shares of Surgery Partners in a research report on Monday, October 14th. They issued a “buy” rating and a $38.00 price target on the stock. Citigroup dropped their price objective on shares of Surgery Partners from $38.00 to $36.00 and set a “buy” rating on the stock in a research note on Wednesday, August 7th. Benchmark reissued a “buy” rating and issued a $50.00 target price on shares of Surgery Partners in a report on Monday, August 26th. Finally, StockNews.com lowered Surgery Partners from a “hold” rating to a “sell” rating in a report on Wednesday, August 7th. One equities research analyst has rated the stock with a sell rating, two have assigned a hold rating and six have issued a buy rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus price target of $38.71.

Surgery Partners Price Performance

Shares of NASDAQ:SGRY opened at $23.01 on Friday. The company has a current ratio of 1.80, a quick ratio of 1.66 and a debt-to-equity ratio of 0.99. The firm’s 50 day moving average is $29.86 and its two-hundred day moving average is $28.35. The firm has a market capitalization of $2.92 billion, a P/E ratio of -47.94, a PEG ratio of 19.44 and a beta of 2.76. Surgery Partners, Inc. has a 52 week low of $21.36 and a 52 week high of $36.92.

Surgery Partners (NASDAQ:SGRY) last posted its earnings results on Tuesday, November 12th. The company reported $0.19 EPS for the quarter, missing the consensus estimate of $0.25 by ($0.06). Surgery Partners had a negative net margin of 2.03% and a positive return on equity of 2.85%. The business had revenue of $770.40 million during the quarter, compared to analyst estimates of $768.99 million. During the same quarter in the prior year, the business earned $0.15 earnings per share. The firm’s revenue was up 14.3% compared to the same quarter last year. Analysts anticipate that Surgery Partners, Inc. will post 0.73 earnings per share for the current year.

Surgery Partners Profile

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.